JP Stock MarketDetailed Quotes

4521 Kaken Pharmaceutical

Watchlist

4237.0
0.00.00%

20min DelayMarket to Open Dec 20 15:30 JST

194.65BMarket Cap19.92P/E (Static)

Kaken Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

Total revenue

0.57%18.25B

-1.29%72.04B

-0.30%17.36B

-1.28%18.51B

-3.23%18.02B

-0.26%18.15B

-4.01%72.98B

-4.99%17.41B

-6.79%18.75B

-2.68%18.62B

Cost of revenue

1.33%8.2B

0.23%33.51B

3.11%8.68B

-2.37%8.38B

0.98%8.36B

-0.77%8.09B

-2.99%33.43B

-4.00%8.42B

-5.75%8.58B

-1.62%8.28B

Gross profit

-0.04%10.05B

-2.57%38.54B

-3.49%8.68B

-0.34%10.14B

-6.60%9.66B

0.16%10.06B

-4.86%39.56B

-5.89%8.99B

-7.67%10.18B

-3.52%10.35B

Operating expense

7.97%7.3B

-8.02%29.02B

-39.96%8.04B

13.17%6.78B

20.18%7.44B

13.02%6.76B

28.75%31.55B

109.83%13.39B

-2.89%5.99B

1.41%6.19B

Staff costs

-2.97%1.73B

-0.99%7.12B

1.87%1.85B

-1.34%1.76B

-3.57%1.73B

-0.94%1.78B

-2.88%7.19B

-2.94%1.82B

-2.46%1.79B

-1.75%1.79B

Research and development costs

15.31%3B

-20.56%12.54B

-57.37%4.04B

39.60%2.76B

36.43%3.14B

28.08%2.6B

87.52%15.79B

297.44%9.48B

-2.32%1.98B

7.33%2.3B

Depreciation and amortization

----

8.93%317M

----

12.79%291M

----

-Depreciation

----

8.93%317M

----

12.79%291M

----

Other operating expenses

8.15%2.57B

9.18%9.04B

1.61%1.83B

1.30%2.25B

22.65%2.58B

10.50%2.38B

-1.71%8.28B

-3.48%1.8B

-3.72%2.23B

-1.82%2.1B

Operating profit

-16.48%2.75B

18.93%9.52B

114.59%641M

-19.69%3.36B

-46.54%2.22B

-18.80%3.3B

-53.11%8B

-238.35%-4.39B

-13.75%4.19B

-10.03%4.15B

Net non-operating interest income (expenses)

50.00%-1M

10.00%-9M

33.33%-2M

-50.00%-3M

0.00%-2M

33.33%-2M

9.09%-10M

25.00%-3M

0.00%-2M

Non-operating interest income

100.00%4M

14.29%8M

0.00%2M

100.00%2M

16.67%7M

100.00%2M

0.00%2M

Non-operating interest expense

25.00%5M

0.00%17M

-20.00%4M

25.00%5M

0.00%4M

0.00%17M

0.00%5M

0.00%4M

Net investment income

35.90%265M

-4.41%412M

75.00%7M

7.22%208M

-50.00%2M

-14.85%195M

20.06%431M

150.00%4M

22.01%194M

300.00%4M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

-605M

69.23%-8M

55.56%-12M

-2,700.00%-26M

-2,800.00%-27M

Income from associates and other participating interests

Special income (charges)

10.81%-33M

91.26%-167M

94.98%-79M

-111.11%-19M

-700.00%-32M

88.54%-37M

47.79%-1.91B

58.50%-1.57B

18.18%-9M

-102.67%-4M

Less:Other special charges

-10.81%33M

214.89%148M

300.00%60M

111.11%19M

700.00%32M

94.74%37M

-92.92%47M

-98.12%15M

-18.18%9M

102.67%4M

Less:Write off

----

-98.98%19M

-98.78%19M

----

--0

-37.78%1.86B

-47.93%1.56B

--0

Other non-operating income (expenses)

-300.00%-4M

-82.93%57M

-85.47%25M

-65.91%15M

-78.26%15M

-95.92%2M

158.91%334M

207.14%172M

100.00%44M

263.16%69M

Income before tax

-31.30%2.37B

43.70%9.8B

109.89%576M

-19.27%3.56B

-47.71%2.21B

-13.90%3.45B

-50.90%6.82B

-918.18%-5.82B

-12.13%4.41B

-11.71%4.22B

Income tax

-34.36%617M

28.54%1.77B

63.36%-775M

-22.17%955M

-44.21%650M

-14.55%940M

-68.24%1.38B

-1,792.00%-2.12B

-18.04%1.23B

-18.07%1.17B

Net income

-30.12%1.75B

47.52%8.03B

136.40%1.35B

-18.15%2.61B

-49.04%1.56B

-13.66%2.51B

-43.03%5.44B

-432.14%-3.71B

-9.65%3.19B

-8.99%3.06B

Net income continuous operations

-30.15%1.75B

47.54%8.03B

136.42%1.35B

-18.15%2.61B

-49.05%1.56B

-13.65%2.51B

-43.03%5.44B

-432.14%-3.71B

-9.62%3.19B

-9.02%3.06B

Noncontrolling interests

Net income attributable to the company

-30.12%1.75B

47.52%8.03B

136.40%1.35B

-18.15%2.61B

-49.04%1.56B

-13.66%2.51B

-43.03%5.44B

-432.14%-3.71B

-9.65%3.19B

-8.99%3.06B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-30.12%1.75B

47.52%8.03B

136.40%1.35B

-18.15%2.61B

-49.04%1.56B

-13.66%2.51B

-43.03%5.44B

-432.14%-3.71B

-9.65%3.19B

-8.99%3.06B

Gross dividend payment

Basic earnings per share

-30.86%46.32

46.87%212.67

136.11%35.57

-18.89%68.92

-49.42%41.19

-12.90%66.99

-42.41%144.8

-447.89%-98.51

-8.80%84.97

-7.95%81.43

Diluted earnings per share

-30.86%46.32

46.87%212.67

135.94%35.57

-18.98%68.841

-49.42%41.19

-12.90%66.99

-42.41%144.8

-437.04%-98.9781

-8.80%84.97

-7.95%81.43

Dividend per share

0.00%150

0.00%75

0.00%150

0.00%75

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022
Total revenue	0.57%18.25B	-1.29%72.04B	-0.30%17.36B	-1.28%18.51B	-3.23%18.02B	-0.26%18.15B	-4.01%72.98B	-4.99%17.41B	-6.79%18.75B	-2.68%18.62B
Cost of revenue	1.33%8.2B	0.23%33.51B	3.11%8.68B	-2.37%8.38B	0.98%8.36B	-0.77%8.09B	-2.99%33.43B	-4.00%8.42B	-5.75%8.58B	-1.62%8.28B
Gross profit	-0.04%10.05B	-2.57%38.54B	-3.49%8.68B	-0.34%10.14B	-6.60%9.66B	0.16%10.06B	-4.86%39.56B	-5.89%8.99B	-7.67%10.18B	-3.52%10.35B
Operating expense	7.97%7.3B	-8.02%29.02B	-39.96%8.04B	13.17%6.78B	20.18%7.44B	13.02%6.76B	28.75%31.55B	109.83%13.39B	-2.89%5.99B	1.41%6.19B
Staff costs	-2.97%1.73B	-0.99%7.12B	1.87%1.85B	-1.34%1.76B	-3.57%1.73B	-0.94%1.78B	-2.88%7.19B	-2.94%1.82B	-2.46%1.79B	-1.75%1.79B
Research and development costs	15.31%3B	-20.56%12.54B	-57.37%4.04B	39.60%2.76B	36.43%3.14B	28.08%2.6B	87.52%15.79B	297.44%9.48B	-2.32%1.98B	7.33%2.3B
Depreciation and amortization	----	8.93%317M	----	----	----	----	12.79%291M	----	----	----
-Depreciation	----	8.93%317M	----	----	----	----	12.79%291M	----	----	----
Other operating expenses	8.15%2.57B	9.18%9.04B	1.61%1.83B	1.30%2.25B	22.65%2.58B	10.50%2.38B	-1.71%8.28B	-3.48%1.8B	-3.72%2.23B	-1.82%2.1B
Operating profit	-16.48%2.75B	18.93%9.52B	114.59%641M	-19.69%3.36B	-46.54%2.22B	-18.80%3.3B	-53.11%8B	-238.35%-4.39B	-13.75%4.19B	-10.03%4.15B
Net non-operating interest income (expenses)	50.00%-1M	10.00%-9M	33.33%-2M	-50.00%-3M	0.00%-2M	33.33%-2M	9.09%-10M	25.00%-3M	0.00%-2M	0.00%-2M
Non-operating interest income	100.00%4M	14.29%8M	0.00%2M	0.00%2M	0.00%2M	100.00%2M	16.67%7M	100.00%2M	0.00%2M	0.00%2M
Non-operating interest expense	25.00%5M	0.00%17M	-20.00%4M	25.00%5M	0.00%4M	0.00%4M	0.00%17M	0.00%5M	0.00%4M	0.00%4M
Net investment income	35.90%265M	-4.41%412M	75.00%7M	7.22%208M	-50.00%2M	-14.85%195M	20.06%431M	150.00%4M	22.01%194M	300.00%4M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	-605M	69.23%-8M	55.56%-12M	0			-2,700.00%-26M	-2,800.00%-27M	0
Income from associates and other participating interests
Special income (charges)	10.81%-33M	91.26%-167M	94.98%-79M	-111.11%-19M	-700.00%-32M	88.54%-37M	47.79%-1.91B	58.50%-1.57B	18.18%-9M	-102.67%-4M
Less:Other special charges	-10.81%33M	214.89%148M	300.00%60M	111.11%19M	700.00%32M	94.74%37M	-92.92%47M	-98.12%15M	-18.18%9M	102.67%4M
Less:Write off	----	-98.98%19M	-98.78%19M	----	----	--0	-37.78%1.86B	-47.93%1.56B	--0	--0
Other non-operating income (expenses)	-300.00%-4M	-82.93%57M	-85.47%25M	-65.91%15M	-78.26%15M	-95.92%2M	158.91%334M	207.14%172M	100.00%44M	263.16%69M
Income before tax	-31.30%2.37B	43.70%9.8B	109.89%576M	-19.27%3.56B	-47.71%2.21B	-13.90%3.45B	-50.90%6.82B	-918.18%-5.82B	-12.13%4.41B	-11.71%4.22B
Income tax	-34.36%617M	28.54%1.77B	63.36%-775M	-22.17%955M	-44.21%650M	-14.55%940M	-68.24%1.38B	-1,792.00%-2.12B	-18.04%1.23B	-18.07%1.17B
Net income	-30.12%1.75B	47.52%8.03B	136.40%1.35B	-18.15%2.61B	-49.04%1.56B	-13.66%2.51B	-43.03%5.44B	-432.14%-3.71B	-9.65%3.19B	-8.99%3.06B
Net income continuous operations	-30.15%1.75B	47.54%8.03B	136.42%1.35B	-18.15%2.61B	-49.05%1.56B	-13.65%2.51B	-43.03%5.44B	-432.14%-3.71B	-9.62%3.19B	-9.02%3.06B
Noncontrolling interests		0	0			0	0	0	0	0
Net income attributable to the company	-30.12%1.75B	47.52%8.03B	136.40%1.35B	-18.15%2.61B	-49.04%1.56B	-13.66%2.51B	-43.03%5.44B	-432.14%-3.71B	-9.65%3.19B	-8.99%3.06B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-30.12%1.75B	47.52%8.03B	136.40%1.35B	-18.15%2.61B	-49.04%1.56B	-13.66%2.51B	-43.03%5.44B	-432.14%-3.71B	-9.65%3.19B	-8.99%3.06B
Gross dividend payment
Basic earnings per share	-30.86%46.32	46.87%212.67	136.11%35.57	-18.89%68.92	-49.42%41.19	-12.90%66.99	-42.41%144.8	-447.89%-98.51	-8.80%84.97	-7.95%81.43
Diluted earnings per share	-30.86%46.32	46.87%212.67	135.94%35.57	-18.98%68.841	-49.42%41.19	-12.90%66.99	-42.41%144.8	-437.04%-98.9781	-8.80%84.97	-7.95%81.43
Dividend per share	0	0.00%150	0.00%75	0	0.00%75	0	0.00%150	0.00%75	0	0.00%75
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Heat List

Overall

No Data